Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.72 - $10.87 $112,712 - $158,702
14,600 New
14,600 $156,000
Q4 2022

Feb 14, 2023

SELL
$4.53 - $7.55 $33,975 - $56,625
-7,500 Reduced 13.86%
46,600 $307,000
Q3 2022

Nov 14, 2022

BUY
$4.97 - $7.89 $268,877 - $426,849
54,100 New
54,100 $285,000
Q2 2020

Aug 14, 2020

BUY
$26.1 - $34.6 $357,570 - $474,020
13,700 New
13,700 $418,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $287M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.